Novozymes Biopharma has published data demonstrating the ability of Recombumin, an excipient, to protect against aggregation, oxidation and non-specific adsorption.
Denmark's Novozymes has renewed and extended its collaboration with
UK-based biotech Upperton Limited on a drug delivery system that
exploits the natural binding properties of recombinant protein
nanoparticles to improve compound...
Danish biotechnology firm Novozymes has acquired Delta
Biotechnology from sanofi-aventis, looking to strengthen its
bioprocessing expertise in enzymes and microorganisms with Delta's
ability to manufacture recombinant proteins...